{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T03:20:55Z","timestamp":1769916055077,"version":"3.49.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T00:00:00Z","timestamp":1646870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T00:00:00Z","timestamp":1646870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s12185-022-03313-z","type":"journal-article","created":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T22:20:41Z","timestamp":1646950841000},"page":"873-881","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Unrelated cord blood transplantation for adult-onset EBV-associated T-cell and NK-cell lymphoproliferative disorders"],"prefix":"10.1007","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0032-6994","authenticated-orcid":false,"given":"Yasushi","family":"Onishi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Onodera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Fukuhara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Ichikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohru","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisayuki","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minami","family":"Yamada-Fujiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Harigae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,10]]},"reference":[{"issue":"7","key":"3313_CR1","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1056\/NEJM200008173430707","volume":"343","author":"JI Cohen","year":"2000","unstructured":"Cohen JI. Epstein-Barr virus infection. N Engl J Med. 2000;343(7):481\u201392. https:\/\/doi.org\/10.1056\/NEJM200008173430707.","journal-title":"N Engl J Med"},{"issue":"3","key":"3313_CR2","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1182\/blood-2011-10-381921","volume":"119","author":"H Kimura","year":"2012","unstructured":"Kimura H, Ito Y, Kawabe S, Gotoh K, Takahashi Y, Kojima S, et al. EBV-associated T\/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases. Blood. 2012;119(3):673\u201386. https:\/\/doi.org\/10.1182\/blood-2011-10-381921.","journal-title":"Blood"},{"key":"3313_CR3","first-page":"355","volume-title":"WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues","author":"L Quintanilla-Martinez","year":"2017","unstructured":"Quintanilla-Martinez L, Ko Y-H, Kimura H, Jaffe ES, et al. EBV-positive T-cell and NK-cell lymphoproliferative diseases of childhood. In: Swerdlow SH, Campo E, Harris NL, et al., editors. WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon: IARC Press; 2017. p. 355\u201363.","edition":"4"},{"issue":"6","key":"3313_CR4","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.3324\/haematol.2017.174177","volume":"103","author":"K Kawamoto","year":"2018","unstructured":"Kawamoto K, Miyoshi H, Suzuki T, Kozai Y, Kato K, Miyahara M, et al. A distinct subtype of Epstein-Barr virus-positive T\/NK-cell lymphoproliferative disorder: adult patients with chronic active Epstein-Barr virus infection-like features. Haematologica. 2018;103(6):1018\u201328. https:\/\/doi.org\/10.3324\/haematol.2017.174177.","journal-title":"Haematologica"},{"issue":"1","key":"3313_CR5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.pathol.2019.09.011","volume":"52","author":"SS Hue","year":"2020","unstructured":"Hue SS, Oon ML, Wang S, Tan SY, Ng SB. Epstein-Barr virus-associated T- and NK-cell lymphoproliferative diseases: an update and diagnostic approach. Pathology. 2020;52(1):111\u201327. https:\/\/doi.org\/10.1016\/j.pathol.2019.09.011.","journal-title":"Pathology"},{"issue":"1","key":"3313_CR6","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/bmt.2010.122","volume":"46","author":"K Kawa","year":"2011","unstructured":"Kawa K, Sawada A, Sato M, Okamura T, Sakata N, Kondo O, et al. Excellent outcome of allogeneic hematopoietic SCT with reduced-intensity conditioning for the treatment of chronic active EBV infection. Bone Marrow Transpl. 2011;46(1):77\u201383. https:\/\/doi.org\/10.1038\/bmt.2010.122.","journal-title":"Bone Marrow Transpl"},{"issue":"9225","key":"3313_CR7","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0140-6736(00)02488-0","volume":"356","author":"T Okamura","year":"2000","unstructured":"Okamura T, Hatsukawa Y, Arai H, Inoue M, Kawa K. Blood stem-cell transplantation for chronic active Epstein-Barr virus with lymphoproliferation. Lancet. 2000;356(9225):223\u20134. https:\/\/doi.org\/10.1016\/S0140-6736(00)02488-0.","journal-title":"Lancet"},{"issue":"3","key":"3313_CR8","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/ajh.20430","volume":"80","author":"M Ishimura","year":"2005","unstructured":"Ishimura M, Ohga S, Nomura A, Toubo T, Morihana E, Saito Y, et al. Successful umbilical cord blood transplantation for severe chronic active Epstein-Barr virus infection after the double failure of hematopoietic stem cell transplantation. Am J Hematol. 2005;80(3):207\u201312. https:\/\/doi.org\/10.1002\/ajh.20430.","journal-title":"Am J Hematol"},{"issue":"9","key":"3313_CR9","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1002\/ajh.21247","volume":"83","author":"E Sato","year":"2008","unstructured":"Sato E, Ohga S, Kuroda H, Yoshiba F, Nishimura M, Nagasawa M, et al. Allogeneic hematopoietic stem cell transplantation for Epstein\u2013Barr virus-associated T\/natural killer-cell lymphoproliferative disease in Japan. Am J Hematol. 2008;83(9):721\u20137. https:\/\/doi.org\/10.1002\/ajh.21247.","journal-title":"Am J Hematol"},{"issue":"2","key":"3313_CR10","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/j.1399-3046.2008.01005.x","volume":"13","author":"T Matsunaga","year":"2009","unstructured":"Matsunaga T, Kurosawa H, Okuya M, Nakajima D, Hagisawa S, Sato Y, et al. Chronic active Epstein\u2013Barr virus infection with mosquito allergy successfully treated with reduced-intensity unrelated allogeneic bone marrow transplantation in a boy. Pediatr Transpl. 2009;13(2):231\u20134. https:\/\/doi.org\/10.1111\/j.1399-3046.2008.01005.x.","journal-title":"Pediatr Transpl"},{"issue":"22","key":"3313_CR11","doi-asserted-by":"publisher","first-page":"5835","DOI":"10.1182\/blood-2010-11-316745","volume":"117","author":"JI Cohen","year":"2011","unstructured":"Cohen JI, Jaffe ES, Dale JK, Pittaluga S, Heslop HE, Rooney CM, et al. Characterization and treatment of chronic active Epstein\u2013Barr virus disease: a 28-year experience in the United States. Blood. 2011;117(22):5835\u201349. https:\/\/doi.org\/10.1182\/blood-2010-11-316745.","journal-title":"Blood"},{"issue":"3","key":"3313_CR12","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/ejh.12151","volume":"91","author":"Y Watanabe","year":"2013","unstructured":"Watanabe Y, Sasahara Y, Satoh M, Looi CY, Katayama S, Suzuki T, et al. A case series of CAEBV of children and young adults treated with reduced-intensity conditioning and allogeneic bone marrow transplantation: a single-center study. Eur J Haematol. 2013;91(3):242\u20138. https:\/\/doi.org\/10.1111\/ejh.12151.","journal-title":"Eur J Haematol"},{"issue":"4","key":"3313_CR13","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1086\/367988","volume":"187","author":"H Kimura","year":"2003","unstructured":"Kimura H, Morishima T, Kanegane H, Ohga S, Hoshino Y, Maeda A, et al. Prognostic factors for chronic active Epstein\u2013Barr virus infection. J Infect Dis. 2003;187(4):527\u201333. https:\/\/doi.org\/10.1086\/367988.","journal-title":"J Infect Dis"},{"issue":"13","key":"3313_CR14","doi-asserted-by":"publisher","first-page":"2918","DOI":"10.1182\/bloodadvances.2020001451","volume":"4","author":"I Yonese","year":"2020","unstructured":"Yonese I, Sakashita C, Imadome KI, Kobayashi T, Yamamoto M, Sawada A, et al. Nationwide survey of systemic chronic active EBV infection in Japan in accordance with the new WHO classification. Blood Adv. 2020;4(13):2918\u201326. https:\/\/doi.org\/10.1182\/bloodadvances.2020001451.","journal-title":"Blood Adv"},{"issue":"5","key":"3313_CR15","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1007\/s12185-011-0831-x","volume":"93","author":"A Arai","year":"2011","unstructured":"Arai A, Imadome KI, Watanabe Y, Yoshimori M, Koyama T, Kawaguchi T, et al. Clinical features of adult-onset chronic active Epstein\u2013Barr virus infection: a retrospective analysis. Int J Hematol. 2011;93(5):602\u20139. https:\/\/doi.org\/10.1007\/s12185-011-0831-x.","journal-title":"Int J Hematol"},{"issue":"2","key":"3313_CR16","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.bbmt.2013.10.026","volume":"20","author":"A Sawada","year":"2014","unstructured":"Sawada A, Inoue M, Koyama-Sato M, Kondo O, Yamada K, Shimizu M, et al. Umbilical cord blood as an alternative source of reduced-intensity hematopoietic stem cell transplantation for chronic Epstein\u2013Barr virus-associated T or natural killer cell lymphoproliferative diseases. Biol Blood Marrow Transpl. 2014;20(2):214\u201321. https:\/\/doi.org\/10.1016\/j.bbmt.2013.10.026.","journal-title":"Biol Blood Marrow Transpl"},{"issue":"5","key":"3313_CR17","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1532\/IJH97.06115","volume":"85","author":"M Nakagawa","year":"2007","unstructured":"Nakagawa M, Hashino S, Takahata M, Kawamura T, Fujisawa F, Kahata K, et al. Successful reduced-intensity stem cell transplantation with cord blood for a poor-prognosis adult with refractory chronic active Epstein\u2013Barr virus infection. Int J Hematol. 2007;85(5):443\u20135. https:\/\/doi.org\/10.1532\/IJH97.06115.","journal-title":"Int J Hematol"},{"issue":"3","key":"3313_CR18","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1136\/jclinpath-2011-200523","volume":"65","author":"Y Isobe","year":"2012","unstructured":"Isobe Y, Aritaka N, Setoguchi Y, Ito Y, Kimura H, Hamano Y, et al. T\/NK cell type chronic active Epstein\u2013Barr virus disease in adults: an underlying condition for Epstein\u2013Barr virus-associated T\/NK-cell lymphoma. J Clin Pathol. 2012;65(3):278\u201382. https:\/\/doi.org\/10.1136\/jclinpath-2011-200523.","journal-title":"J Clin Pathol"},{"issue":"10","key":"3313_CR19","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1038\/bmt.2014.129","volume":"49","author":"Y Onishi","year":"2014","unstructured":"Onishi Y, Sugimura K, Ohba R, Imadome K, Shimokawa H, Harigae H. Resolution of chronic active EBV infection and coexisting pulmonary arterial hypertension after cord blood transplantation. Bone Marrow Transpl. 2014;49(10):1343\u20134. https:\/\/doi.org\/10.1038\/bmt.2014.129.","journal-title":"Bone Marrow Transpl"},{"issue":"23","key":"3313_CR20","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.2169\/internalmedicine.55.7432","volume":"55","author":"M Saburi","year":"2016","unstructured":"Saburi M, Ogata M, Satou T, Yoshida N, Nagamatsu K, Nashimoto Y, et al. Successful cord blood stem cell transplantation for an adult case of chronic active epstein\u2013barr virus infection. Intern Med. 2016;55(23):3499\u2013504. https:\/\/doi.org\/10.2169\/internalmedicine.55.7432.","journal-title":"Intern Med"},{"issue":"9","key":"3313_CR21","doi-asserted-by":"publisher","first-page":"e28536","DOI":"10.1002\/pbc.28536","volume":"67","author":"A Mayumi","year":"2020","unstructured":"Mayumi A, Sawada A, Sato M, Shimizu M, Ioi A, Higuchi K, et al. Impact of melphalan dose during reduced-intensity conditioning on engraftment of cord blood transplantation for chronic Epstein\u2013Barr virus-associated T or NK cell lymphoproliferative diseases. Pediatr Blood Cancer. 2020;67(9):e28536. https:\/\/doi.org\/10.1002\/pbc.28536.","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"3313_CR22","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/bmt.2016.3","volume":"51","author":"A Arai","year":"2016","unstructured":"Arai A, Sakashita C, Hirose C, Imadome KI, Yamamoto M, Jinta M, et al. Hematopoietic stem cell transplantation for adults with EBV-positive T- or NK-cell lymphoproliferative disorders: efficacy and predictive markers. Bone Marrow Transpl. 2016;51(6):879\u201382. https:\/\/doi.org\/10.1038\/bmt.2016.3.","journal-title":"Bone Marrow Transpl"},{"issue":"1","key":"3313_CR23","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/ajh.20398","volume":"80","author":"M Okano","year":"2005","unstructured":"Okano M, Kawa K, Kimura H, Yachie A, Wakiguchi H, Maeda A, et al. Proposed guidelines for diagnosing chronic active Epstein\u2013Barr virus infection. Am J Hematol. 2005;80(1):64\u20139. https:\/\/doi.org\/10.1002\/ajh.20398.","journal-title":"Am J Hematol"},{"issue":"2","key":"3313_CR24","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"JI Henter","year":"2007","unstructured":"Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124\u201331. https:\/\/doi.org\/10.1002\/pbc.21039.","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"3313_CR25","first-page":"825","volume":"15","author":"D Przepiorka","year":"1995","unstructured":"Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, et al. 1994 consensus conference on acute GVHD grading. Bone Marrow Transpl. 1995;15(6):825\u20138.","journal-title":"Bone Marrow Transpl"},{"issue":"2","key":"3313_CR26","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/0002-9343(80)90380-0","volume":"69","author":"HM Shulman","year":"1980","unstructured":"Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE, et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med. 1980;69(2):204\u201317.","journal-title":"Am J Med"},{"issue":"3","key":"3313_CR27","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics. Bone Marrow Transpl. 2013;48(3):452\u20138. https:\/\/doi.org\/10.1038\/bmt.2012.244.","journal-title":"Bone Marrow Transpl"},{"issue":"2","key":"3313_CR28","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1182\/blood.V96.2.443","volume":"96","author":"L Quintanilla-Martinez","year":"2000","unstructured":"Quintanilla-Martinez L, Kumar S, Fend F, Reyes E, Teruya-Feldstein J, Kingma DW, et al. Fulminant EBV(+) T-cell lymphoproliferative disorder following acute\/chronic EBV infection: a distinct clinicopathologic syndrome. Blood. 2000;96(2):443\u201351.","journal-title":"Blood"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-022-03313-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-022-03313-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-022-03313-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T13:33:42Z","timestamp":1654090422000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-022-03313-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,10]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["3313"],"URL":"https:\/\/doi.org\/10.1007\/s12185-022-03313-z","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,10]]},"assertion":[{"value":"17 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}